Dr Eva Krpelanova, is medical officer in the team of Classifications and Terminologies, World Health Organization (WHO).

She is a pathologist, worked in the Netherlands both in the clinical pathology and as a medical officer responsible for the mortality statistics at the Statistics Netherlands until joining WHO in 2021.

Eva is responsible for the medical related matters in the WHO – Family of International Classifications (WHO-FIC), especially International Classifications Diseases 11th revision (ICD-11). Eva was born and raised in Slovakia.

Dr Ariana Znaor, MD, MSc, PhD is a scientist at the International Agency for Research on Cancer (IARC). Within the Global Initiative for Cancer Registry Development program (GICR), she is responsible for coordination of the Regional Hub for Cancer Registration in Izmir (covering Northern Africa, Central and Western Asia).

Before joining IARC in 2013, Dr Znaor was the director of the Croatian National Cancer Registry for 13 years, as well as associate professor of epidemiology at the Andrija Stampar School of Public Health, Zagreb. She completed her MD, MSc and PhD degrees at the University of Zagreb, Croatia.

Her areas of expertise are cancer registration and descriptive epidemiology. She is one of the editors of the Cancer Incidence in Five Continents publications (Volume XI and Vol XII, in progress) with a specific area of interest in tumour classifications. Since the establishment of the Izmir Hub in 2013, she has organised more than 25 regional cancer registration courses, workshops and constant support to cancer registries in the Hub region. Dr Znaor is author of more than 140 peer-reviewed articles (Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=Znaor+A).

Dr Prashant Mathur is a pediatrician, having completed his post graduation and PhD in Pediatric Gastroenterology & Hepatology from the All India Institute of Medical Sciences (AIIMS) New Delhi. He has further experience in clinical epidemiology, program evaluation and evidence to policy translation. He initiated several major projects of ICMR, worked with WHO and was nodal officer of ICMR international collaborations with several agencies and universities.

At present, he is Director of the ICMR National Centre for Disease Informatics and Research, Bengaluru since May 2016 wherein work involves research on epidemiology, patterns of care and survival studies on cancer, stroke, cardiovascular diseases, diabetes and their risk factors. He is inc harge of the National Cancer Registry Program in India. The work at NCDIR informs policy and program for NCD prevention and control in India.

Dr Mathur has over 90 peer reviewed publications in national and international journals and chapters in 19 books.

CIBERESP's Scientific Director, Marina Pollán, is also Director of the National Epidemiology Center of the Carlos III Health Institute (CNE-ISCIII). Marina is a Doctor of Medicine specialising in preventive medicine and public health. Her doctoral thesis, dedicated to breast cancer, earned her the extraordinary doctorate award.

She has worked in cancer epidemiology at the CNE since 1990. In 2016, she attained status of research professor by competitive examination. In 2017, she was appointed scientific director of CIBERESP, leading one of the research groups of this consortium. Its priority area of reseach are on cancer risk factors, mainly those associated with lifestyle. Dr Pollan co-leads the multicenter project MCC-Spain, one of CIBERESP's strategic actions. She is the principal investigator of numerous studies generally related to breast cancer and a member of the Spanish Breast Cancer Research Group. Recently, she had assumed the coordination of the Chronic Diseases program at CIBERESP.

Marina has published more than 300 scientific articles (H index=33), in the field of epidemiology and control of cancer. She has been involved in outreach activities aimed at transferring existing knowledge about the cancer situation and its main risk factors to the general population. She has extensive teaching experience in different areas of cancer epidemiology and epidemiological methodology.

Dr. Lynne Penberthy is the Associate Director for the Surveillance Research Program (SRP), Division of Cancer Control and Population Sciences (DCCPS), US National Cancer Institute (NCI). She obtained her MD from the University of Michigan and her MPH in epidemiology at Johns Hopkins. Dr. Penberthy’s career includes a surgical internship in at the Sinai Hospital, Baltimore, Maryland, and a preventive medicine residency at Johns Hopkins University. She completed her post-doctoral training in epidemiology with the CDC as an epidemic intelligence service (EIS) officer. She is licensed to practice medicine in the state of Maryland.

Dr. Penberthy was the Director of Cancer Research Informatics and Services and Associate Professor of General Internal Medicine at the Virginia Commonwealth University Massey Cancer Center. She directed a team in the development of innovative software with the objectives of using existing data for clinical trials eligibility screening, automated capture of treatment data from oncology practice claims, and extraction of clinical characteristics from various electronic medical records (EMR) components. She was also involved in biobanking and annotation of specimens using clinical data. She has 20 years of experience in cancer surveillance and automation using secondary data. Dr. Penberthy has worked on more than 20 grants and contracts as well as 31 publications related to using secondary data and/or informatics tools for cancer surveillance and clinical trials assessment.